Zomedica Pharmaceuticals Corp. focuses on animal diagnostics and therapies in the companion animal industry with an emphasis on developing solutions for previously unmet needs.
Creating a diverse portfolio of diagnostics and therapeutics in the $10B companion animal market.
INITIATION REPORT
NYSE American: ZOM
Initiates coverage on:
Zomedica
Zomedica Pharmaceuticals is a client of PCG Advisory, Inc., an investor relations and communications firm. Please see our disclosures in the research report as well as on our website www.pcgadvisory.com
Download the exclusive report and learn more about: